Tag: Bureau of Competition

Displaying 21 - 40 of 677 results.

Pages

Two of the largest suppliers of gases, American Air Liquide Holdings, Inc. and Airgas, Inc., have agreed to divest certain production and distribution assets to settle Federal Trade Commission charges that their proposed $13.4 billion merger likely would have harmed competition and led to higher...
Statement from Bureau of Competition Director Debbie Feinstein: “Today’s court ruling is great news for business customers in the office supply market. This deal would eliminate head-to-head competition between Staples and Office Depot and likely lead to higher prices and lower quality service for...
Most mergers reviewed by the Commission involve the acquisition of an entire company, or an identifiable set of assets – that is, the buyer seeks to control the assets of the seller through an acquisition. But sometimes companies acquire only a partial interest in a competitor – and...
The Federal Trade Commission has approved a modified final order settling charges that Hikma Pharmaceuticals PLC’s $2 billion acquisition of  Roxane Laboratories Inc. and Boehringer Ingelheim Roxane, Inc. from Boehringer Ingelheim Corporation would likely be anticompetitive.
Federal Trade Commission staff submitted written comments opposing proposed legislation in Alabama that purports to immunize “authorities” formed by any public university operating a medical school in Alabama, and their collaborative activities “with all types of health care providers,” from the...
The Federal Trade Commission is currently accepting public comments on ProMedica Health Systems’ application to divest St. Luke’s Hospital. The divestiture is required by the Commission’s final order issued in connection with the Commission’s ruling that ProMedica’s acquisition of former rival St.
Testifying on behalf of the Federal Trade Commission before a subcommittee of the U.S. House of Representatives’ Committee on Energy and Commerce, Tara Koslov, Deputy Director of the FTC’s Office of Policy Planning, described the state of competition in the pet medications industry, as well as the...
A company that supplies some of the world’s largest medical device makers with a high-performance polymer used to make spinal and other medical implants has agreed to settle Federal Trade Commission charges that it violated federal antitrust law by using long-term exclusive contracts to maintain...
Recently, President Obama issued a call to all executive departments and agencies “to promote competition, arm consumers and workers with the information they need to make informed choices, and eliminate regulations that restrict competition without corresponding benefits to the...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Lupin’s proposed $850 million acquisition of Gavis would likely be anticompetitive. Under the order, first announced in February 2016, the companies are required to
Star Pipe Products, Ltd., a supplier of ductile iron pipe fittings, will pay $120,000 in civil penalties to resolve Federal Trade Commission allegations that it violated a 2012 Commission order prohibiting it from sharing competitively sensitive information. It also has agreed to an order...
Federal Trade Commission Chairwoman Edith Ramirez and Assistant Attorney General Bill Baer of the U.S. Department of Justice’s Antitrust Division participated in high level bilateral meetings with officials responsible for China’s three anti-monopoly agencies – National Development and Reform...
The Federal Trade Commission and the Department of Justice today issued a joint statement reaffirming the importance of preserving competition in the defense industry.
Once a year, the ABA Antitrust Section Spring Meeting presents the perfect occasion to take stock of the Bureau’s work. This has been an especially busy year for the Bureau of Competition, requiring extraordinary effort from our attorneys and support staff to keep up with the...
Following a public comment period, the Federal Trade Commission has approved an application by Pfizer Inc. to modify the FTC’s January 2010 final order, which settled the FTC’s competition concerns arising from Pfizer’s 2009 acquisition of Wyeth.
Federal Trade Commission Chairwoman Edith Ramirez released the FTC’s 2015 Annual Highlights today, featuring some of the agency’s key efforts to benefit consumers and promote competition over the past calendar year.
The Federal Trade Commission has approved a modified final order settling charges that Hikma Pharmaceuticals PLC’s acquisition of the rights to various drug products and related assets from Ben Venue Laboratories, Inc. was anticompetitive.
The Federal Trade Commission filed a complaint in federal district court alleging that Endo Pharmaceuticals Inc. and several other drug companies violated antitrust laws by using pay-for-delay settlements to block consumers’ access to lower-cost generic versions of Opana ER and Lidoderm. Following...
For more than 15 years, one of the FTC’s top priorities has been to put an end to anticompetitive reverse-payment settlements between brand-name drug makers and their potential generic rivals. In our view, these settlements are anticompetitive agreements not to compete in which the...
Federal Trade Commission staff submitted a comment, as public testimony, to the Alaska legislature on proposed legislation that would allow licensed Alaska physicians located out-of-state to provide telehealth services in the same manner as in-state physicians. 

Pages